Chemotherapy Exposure and outcomes of Chronic Lymphoid Leukemia Patients
Open Access
- 1 March 2017
- journal article
- Published by Heighten Science Publications Corporation
- Vol. 2 (1), 025-033
- https://doi.org/10.29328/journal.jcicm.1001006
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatmentAmerican Journal of Hematology, 2013
- Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular studyHuman Pathology, 2013
- Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE projectBlood, 2010
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trialThe Lancet, 2010
- New opportunities for drug outcomes research in cancer patients: The linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage SystemEuropean Journal of Cancer, 2010
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Alemtuzumab Compared With Chlorambucil As First-Line Therapy for Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2007
- Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiologyBritish Journal of Haematology, 2007
- Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2000
- Chemotherapeutic Options in Chronic Lymphocytic Leukemia: a Meta-analysis of the Randomized TrialsJNCI Journal of the National Cancer Institute, 1999